Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The role of the hypothalamic melanocortin system in behavioral appetitive processes.

Benoit SC, Tracy AL, Air EL, Kinzig K, Seeley RJ, Davidson TL.

Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):603-9.

PMID:
11509222
[PubMed - indexed for MEDLINE]
2.

Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.

Grill HJ, Ginsberg AB, Seeley RJ, Kaplan JM.

J Neurosci. 1998 Dec 1;18(23):10128-35.

PMID:
9822766
[PubMed - indexed for MEDLINE]
Free Article
3.

The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.

Strader AD, Schiöth HB, Buntin JD.

Brain Res. 2003 Jan 17;960(1-2):112-21.

PMID:
12505663
[PubMed - indexed for MEDLINE]
4.

Paraventricular hypothalamic alpha-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects.

Wirth MM, Olszewski PK, Yu C, Levine AS, Giraudo SQ.

Peptides. 2001 Jan;22(1):129-34.

PMID:
11179607
[PubMed - indexed for MEDLINE]
5.

Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition.

Azzara AV, Sokolnicki JP, Schwartz GJ.

Physiol Behav. 2002 Nov;77(2-3):411-6.

PMID:
12419417
[PubMed - indexed for MEDLINE]
6.

Melanocortin mediated inhibition of feeding behavior in rats.

Murphy B, Nunes CN, Ronan JJ, Harper CM, Beall MJ, Hanaway M, Fairhurst AM, Van der Ploeg LH, MacIntyre DE, Mellin TN.

Neuropeptides. 1998 Dec;32(6):491-7.

PMID:
9920446
[PubMed - indexed for MEDLINE]
7.

Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function.

Kuo JJ, Silva AA, Hall JE.

Hypertension. 2003 Mar;41(3 Pt 2):768-74. Epub 2002 Dec 30.

PMID:
12623994
[PubMed - indexed for MEDLINE]
Free Article
8.

Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.

Beckman TR, Shi Q, Levine AS, Billington CJ.

Physiol Behav. 2009 Mar 23;96(4-5):568-73. doi: 10.1016/j.physbeh.2008.12.007. Epub 2008 Dec 24.

PMID:
19136019
[PubMed - indexed for MEDLINE]
9.

Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats.

Ploj K, Roman E, Kask A, Hyytiä P, Schiöth HB, Wikberg JE, Nylander I.

Brain Res Bull. 2002 Oct 30;59(2):97-104.

PMID:
12379439
[PubMed - indexed for MEDLINE]
10.

Feeding and behavioural effects of central administration of the melanocortin 3/4-R antagonist SHU9119 in obese and lean Siberian hamsters.

Schuhler S, Horan TL, Hastings MH, Mercer JG, Morgan PJ, Ebling FJ.

Behav Brain Res. 2004 Jul 9;152(2):177-85.

PMID:
15196785
[PubMed - indexed for MEDLINE]
11.

Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

Hwa JJ, Ghibaudi L, Gao J, Parker EM.

Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R444-51.

PMID:
11448846
[PubMed - indexed for MEDLINE]
12.

Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands.

Giraudo SQ, Billington CJ, Levine AS.

Brain Res. 1998 Nov 2;809(2):302-6.

PMID:
9853124
[PubMed - indexed for MEDLINE]
13.

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.

da Silva AA, Kuo JJ, Hall JE.

Hypertension. 2004 Jun;43(6):1312-7. Epub 2004 May 3.

PMID:
15123576
[PubMed - indexed for MEDLINE]
Free Article
14.

Melanocortin receptor agonist transiently increases oxygen consumption in rats.

Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir VH, Franzson L, Schiöth HB.

Neuroreport. 2001 Dec 4;12(17):3703-8.

PMID:
11726778
[PubMed - indexed for MEDLINE]
15.

Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat.

Williams DL, Grill HJ, Weiss SM, Baird JP, Kaplan JM.

Psychopharmacology (Berl). 2002 Apr;161(1):47-53. Epub 2002 Mar 1.

PMID:
11967630
[PubMed - indexed for MEDLINE]
16.

Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ.

Am J Physiol. 1998 Jan;274(1 Pt 2):R248-54.

PMID:
9458925
[PubMed - indexed for MEDLINE]
Free Article
17.

Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats.

Starowicz K, Przewlocki R, Gispen WH, Przewlocka B.

Neuroreport. 2002 Dec 20;13(18):2447-52.

PMID:
12499847
[PubMed - indexed for MEDLINE]
18.

Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction.

Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA.

Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R50-9.

PMID:
10644621
[PubMed - indexed for MEDLINE]
19.

Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats.

Grossman HC, Hadjimarkou MM, Silva RM, Giraudo SQ, Bodnar RJ.

Brain Res. 2003 Nov 21;991(1-2):240-4.

PMID:
14575897
[PubMed - indexed for MEDLINE]
20.

Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins.

Matias I, Vergoni AV, Petrosino S, Ottani A, Pocai A, Bertolini A, Di Marzo V.

Neuropharmacology. 2008 Jan;54(1):206-12. Epub 2007 Jun 29.

PMID:
17675101
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk